• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

使用 α-氨基脒合成新型 5,6,7,8-四氢喹唑啉衍生物及其生物活性的计算机筛选。

Synthesis of Novel Derivatives of 5,6,7,8-Tetrahydroquinazolines Using α-Aminoamidines and In Silico Screening of Their Biological Activity.

机构信息

Institute of Chemistry and School of Chemistry, V. N. Karazin Kharkiv National University, 4 Svobody Sq., 61022 Kharkiv, Ukraine.

State Scientific Institution "Institute for Single Crystals", National Academy of Sciences of Ukraine, 60 Nauky Ave, 61072 Kharkiv, Ukraine.

出版信息

Int J Mol Sci. 2022 Mar 29;23(7):3781. doi: 10.3390/ijms23073781.

DOI:10.3390/ijms23073781
PMID:35409144
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8999073/
Abstract

α-Aminoamidines are promising reagents for the synthesis of a diverse family of pyrimidine ring derivatives. Here, we demonstrate the use of α-aminoamidines for the synthesis of a new series of 5,6,7,8-tetrahydroquinazolines by their reaction with bis-benzylidene cyclohexanones. The reaction occurs in mild conditions and is characterized by excellent yields. It has easy workup, as compared to the existing methods of tetrahydroquinazoline preparation. Newly synthesized derivatives of 5,6,7,8-tetrahydroquinazoline bear protecting groups at the C2--butyl moiety of a quinazoline ring, which can be easily cleaved, opening up further opportunities for their functionalization. Moreover, molecular docking studies indicate that the synthesized compounds reveal high binding affinity toward some essential enzymes of , such as dihydrofolate reductase (DHFR), pantothenate kinase (PanK), and FAD-containing oxidoreductase DprE1 (DprE1), so that they may be promising candidates for the molecular design and the development of new antitubercular agents against multidrug-resistant strains of the . Finally, the high inhibition activity of the synthesized compounds was also predicted against β-glucosidase, suggesting a novel tetrahydroquinazoline scaffold for the treatment of diabetes.

摘要

α-氨基脒是合成各种嘧啶环衍生物的有前途的试剂。在这里,我们展示了α-氨基脒在温和条件下与双苄叉环己酮反应合成一系列新的 5,6,7,8-四氢喹唑啉的用途。与现有的四氢喹唑啉制备方法相比,该反应具有产率优异、操作简便等优点。新合成的 5,6,7,8-四氢喹唑啉衍生物在喹唑啉环的 C2-丁基部分带有保护基团,这些保护基团可以很容易地被切断,为它们的进一步官能化开辟了更多的机会。此外,分子对接研究表明,所合成的化合物对分枝杆菌的一些重要酶(如二氢叶酸还原酶(DHFR)、泛酸激酶(PanK)和含 FAD 的氧化还原酶 DprE1(DprE1))具有高结合亲和力,因此它们可能是针对耐多药分枝杆菌菌株的分子设计和新型抗结核药物开发的有前途的候选药物。最后,还预测了所合成的化合物对β-葡萄糖苷酶的高抑制活性,这表明了一种用于治疗糖尿病的新型四氢喹唑啉骨架。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b231/8999073/70d44f90cb95/ijms-23-03781-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b231/8999073/50e5e2d59233/ijms-23-03781-sch001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b231/8999073/051bccd0d5b2/ijms-23-03781-sch002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b231/8999073/49284cfc0fbc/ijms-23-03781-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b231/8999073/3fed8265bcbe/ijms-23-03781-g002a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b231/8999073/ac43e978fda9/ijms-23-03781-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b231/8999073/e307f07240d4/ijms-23-03781-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b231/8999073/70d44f90cb95/ijms-23-03781-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b231/8999073/50e5e2d59233/ijms-23-03781-sch001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b231/8999073/051bccd0d5b2/ijms-23-03781-sch002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b231/8999073/49284cfc0fbc/ijms-23-03781-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b231/8999073/3fed8265bcbe/ijms-23-03781-g002a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b231/8999073/ac43e978fda9/ijms-23-03781-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b231/8999073/e307f07240d4/ijms-23-03781-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b231/8999073/70d44f90cb95/ijms-23-03781-g005.jpg

相似文献

1
Synthesis of Novel Derivatives of 5,6,7,8-Tetrahydroquinazolines Using α-Aminoamidines and In Silico Screening of Their Biological Activity.使用 α-氨基脒合成新型 5,6,7,8-四氢喹唑啉衍生物及其生物活性的计算机筛选。
Int J Mol Sci. 2022 Mar 29;23(7):3781. doi: 10.3390/ijms23073781.
2
Preparation, biological evaluation and molecular docking study of imidazolyl dihydropyrimidines as potential Mycobacterium tuberculosis dihydrofolate reductase inhibitors.咪唑基二氢嘧啶作为潜在结核分枝杆菌二氢叶酸还原酶抑制剂的制备、生物学评价及分子对接研究
Bioorg Med Chem Lett. 2016 Aug 15;26(16):4030-5. doi: 10.1016/j.bmcl.2016.06.082. Epub 2016 Jun 28.
3
Identification of novel selective Mtb-DHFR inhibitors as antitubercular agents through structure-based computational techniques.通过基于结构的计算技术鉴定新型选择性 Mtb-DHFR 抑制剂作为抗结核药物。
Arch Pharm (Weinheim). 2020 Feb;353(2):e1900287. doi: 10.1002/ardp.201900287. Epub 2019 Dec 23.
4
Synthesis, molecular modeling and bio-evaluation of cycloalkyl fused 2-aminopyrimidines as antitubercular and antidiabetic agents.合成、分子建模和环烷基稠合 2-氨基嘧啶类化合物的生物评价作为抗结核和抗糖尿病药物。
Bioorg Med Chem Lett. 2011 Aug 1;21(15):4404-8. doi: 10.1016/j.bmcl.2011.06.040. Epub 2011 Jun 17.
5
Synthesis, molecular docking study and biological evaluation of new pyrrole scaffolds as potential antitubercular agents for dual targeting of enoyl ACP reductase and dihydrofolate reductase.新型吡咯类支架的合成、分子对接研究及作为烯酰基 ACP 还原酶和二氢叶酸还原酶双重靶点的潜在抗结核剂的生物评价。
PLoS One. 2024 May 13;19(5):e0303173. doi: 10.1371/journal.pone.0303173. eCollection 2024.
6
Synthesis and antiparasitic and antitumor activity of 2, 4-diamino-6-(arylmethyl)-5,6,7,8-tetrahydroquinazoline analogues of piritrexim.吡硫克昔的2,4-二氨基-6-(芳基甲基)-5,6,7,8-四氢喹唑啉类似物的合成及其抗寄生虫和抗肿瘤活性
J Med Chem. 1999 Mar 25;42(6):1007-17. doi: 10.1021/jm980572i.
7
Synthesis, Biological Evaluation and Molecular Docking Studies of New Pyrazolines as an Antitubercular and Cytotoxic Agents.新型吡唑啉类抗结核和细胞毒性药物的合成、生物学评价及分子对接研究
Infect Disord Drug Targets. 2019;19(3):310-321. doi: 10.2174/1871526519666181217120626.
8
In silico design of novel quinazoline-based compounds as potential Mycobacterium tuberculosis PknB inhibitors through 2D and 3D-QSAR, molecular dynamics simulations combined with pharmacokinetic predictions.通过二维和三维定量构效关系、分子动力学模拟结合药代动力学预测,对新型喹唑啉类化合物进行计算机辅助设计,作为潜在的结核分枝杆菌 PknB 抑制剂。
J Mol Graph Model. 2022 Sep;115:108231. doi: 10.1016/j.jmgm.2022.108231. Epub 2022 May 28.
9
Discovery of New Schiff Bases Tethered Pyrazole Moiety: Design, Synthesis, Biological Evaluation, and Molecular Docking Study as Dual Targeting DHFR/DNA Gyrase Inhibitors with Immunomodulatory Activity.新型席夫碱连接吡唑部分的发现:作为具有免疫调节活性的双重靶向 DHFR/DNA 拓扑异构酶抑制剂的设计、合成、生物评价和分子对接研究。
Molecules. 2020 Jun 2;25(11):2593. doi: 10.3390/molecules25112593.
10
Structure determination of tetrahydroquinazoline antifolates in complex with human and Pneumocystis carinii dihydrofolate reductase: correlations between enzyme selectivity and stereochemistry.与人和卡氏肺孢子虫二氢叶酸还原酶复合的四氢喹唑啉抗叶酸剂的结构测定:酶选择性与立体化学之间的相关性
Acta Crystallogr D Biol Crystallogr. 2004 Apr;60(Pt 4):646-55. doi: 10.1107/S0907444904002094. Epub 2004 Mar 23.

引用本文的文献

1
Synthesis of Novel Derivatives of 4,6-Diarylpyrimidines and Dihydro-Pyrimidin-4-one and Screening of Their Anticancer Activity.4,6-二芳基嘧啶和二氢嘧啶-4-酮的新型衍生物的合成及其抗癌活性筛选
Curr Org Synth. 2025;22(4):556-567. doi: 10.2174/0115701794356958241024082646.
2
Binding interactions of hydrophobically-modified flavonols with β-glucosidase: fluorescence spectroscopy and molecular modelling study.疏水改性黄酮醇与β-葡萄糖苷酶的结合相互作用:荧光光谱和分子模拟研究
RSC Adv. 2023 Nov 21;13(48):34107-34121. doi: 10.1039/d3ra06276g. eCollection 2023 Nov 16.

本文引用的文献

1
Research developments in the syntheses, anti-inflammatory activities and structure-activity relationships of pyrimidines.嘧啶的合成、抗炎活性及构效关系的研究进展
RSC Adv. 2021 Feb 3;11(11):6060-6098. doi: 10.1039/d0ra10657g. eCollection 2021 Feb 2.
2
Identification of novel benzothiopyranones with ester and amide motifs derived from active metabolite as promising leads against Mycobacterium tuberculosis.鉴定新型苯并噻吩酮类化合物,其结构来源于活性代谢物中的酯和酰胺基序,有望成为抗结核分枝杆菌的先导化合物。
Eur J Med Chem. 2021 Oct 15;222:113603. doi: 10.1016/j.ejmech.2021.113603. Epub 2021 Jun 5.
3
Synthesis, Biological Activity, and Molecular Dynamics Study of Novel Series of a Trimethoprim Analogs as Multi-Targeted Compounds: Dihydrofolate Reductase (DHFR) Inhibitors and DNA-Binding Agents.
新型系列三甲氧嘧啶类似物的合成、生物活性及分子动力学研究:二氢叶酸还原酶(DHFR)抑制剂和 DNA 结合剂的多靶点化合物。
Int J Mol Sci. 2021 Apr 1;22(7):3685. doi: 10.3390/ijms22073685.
4
A simple and portable method for β-Glucosidase activity assay and its inhibitor screening based on a personal glucose meter.一种基于个人血糖仪的β-葡萄糖苷酶活性测定及其抑制剂筛选的简单便携方法。
Anal Chim Acta. 2021 Jan 15;1142:19-27. doi: 10.1016/j.aca.2020.10.047. Epub 2020 Oct 27.
5
Novel, Potent, and Druglike Tetrahydroquinazoline Inhibitor That Is Highly Selective for Human Topoisomerase II α over β.新型强效四氢喹唑啉类抑制剂,对人拓扑异构酶 IIα 具有高度选择性,而对 IIβ 选择性较低。
J Med Chem. 2020 Nov 12;63(21):12873-12886. doi: 10.1021/acs.jmedchem.0c00774. Epub 2020 Oct 20.
6
I-Catalyzed Aerobic α,β-Dehydrogenation and Deamination of Tertiary Alkylamines: Highly Selective Synthesis of Polysubstituted Pyrimidines via Hidden Acyclic Enamines.I 催化的叔胺的有氧 α,β-脱氢和脱氨反应:通过隐藏的无环烯胺高选择性合成多取代嘧啶。
Org Lett. 2020 Jul 17;22(14):5645-5649. doi: 10.1021/acs.orglett.0c02001. Epub 2020 Jul 7.
7
Identification of novel selective Mtb-DHFR inhibitors as antitubercular agents through structure-based computational techniques.通过基于结构的计算技术鉴定新型选择性 Mtb-DHFR 抑制剂作为抗结核药物。
Arch Pharm (Weinheim). 2020 Feb;353(2):e1900287. doi: 10.1002/ardp.201900287. Epub 2019 Dec 23.
8
Novel Tetrahydroquinazolinamines as Selective Histamine 3 Receptor Antagonists for the Treatment of Obesity.新型四氢喹唑啉胺类化合物作为选择性组胺 3 受体拮抗剂用于肥胖症的治疗。
J Med Chem. 2019 May 9;62(9):4638-4655. doi: 10.1021/acs.jmedchem.9b00241. Epub 2019 Apr 29.
9
DHFR Inhibitors: Reading the Past for Discovering Novel Anticancer Agents.二氢叶酸还原酶抑制剂:从过去中寻找新型抗癌药物。
Molecules. 2019 Mar 22;24(6):1140. doi: 10.3390/molecules24061140.
10
Investigation of the anti-TB potential of selected propolis constituents using a molecular docking approach.采用分子对接方法研究几种蜂胶成分的抗结核潜力。
Sci Rep. 2018 Aug 16;8(1):12238. doi: 10.1038/s41598-018-30209-y.